These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31789917)

  • 1. FDG PET Findings of Hyperprogression During Immunotherapy in a Patient With Hepatocellular Carcinoma.
    Wang J; Wang X; Yang X; Zhao H; Huo L
    Clin Nucl Med; 2020 Jan; 45(1):92-93. PubMed ID: 31789917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of
    Lee SM; Kim HS; Lee S; Lee JW
    World J Gastroenterol; 2019 Mar; 25(11):1289-1306. PubMed ID: 30918424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of
    Ida Y; Tamai H; Shingaki N; Shimizu R; Maeshima S; Maekita T; Iguchi M; Terada M; Kitano M
    Cancer Imaging; 2020 Oct; 20(1):74. PubMed ID: 33076990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.
    Kim MJ; Kim YS; Cho YH; Jang HY; Song JY; Lee SH; Jeong SW; Kim SG; Jang JY; Kim HS; Kim BS; Lee WH; Park JM; Lee JM; Lee MH; Choi DL
    Korean J Intern Med; 2015 May; 30(3):308-15. PubMed ID: 25995661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implication of (18)F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.
    Shin DY; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):165-75. PubMed ID: 20872146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
    Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG
    J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
    Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
    Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [FDG-PET in hepatocellular carcinoma. Based on one case].
    Gil Martínez EM; Rabadán Bujalance F; Ponce Herrera C; Martínez Obrador D; Moya García F
    Rev Esp Med Nucl; 2004; 23(5):352-3. PubMed ID: 15450142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of 18-FDG-positron emission tomography/computed tomography before and after transarterial chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: initial results.
    Cascales Campos P; Ramirez P; Gonzalez R; Febrero B; Pons JA; Miras M; Sanchez Bueno F; Robles R; Parrilla P
    Transplant Proc; 2011; 43(6):2213-5. PubMed ID: 21839236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma].
    Shin JA; Park JW; An M; Choi JI; Kim SH; Kim SK; Lee WJ; Park SJ; Hong EK; Kim CM
    Korean J Hepatol; 2006 Dec; 12(4):546-52. PubMed ID: 17237633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET for hepatocellular carcinoma presenting with portal vein tumor thrombus.
    Hanajiri K; Mitsui H; Maruyama T; Kondo Y; Shiina S; Omata M; Nakagawa K
    J Gastroenterol; 2005 Oct; 40(10):1005-6. PubMed ID: 16261443
    [No Abstract]   [Full Text] [Related]  

  • 13. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
    Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Iida Y; Higuchi T; Hanaoka H; Miyakubo M; Takano A; Ishikita T; Endo K
    Oncol Rep; 2007 Dec; 18(6):1469-73. PubMed ID: 17982632
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M
    J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.
    Chen YK; Hsieh DS; Liao CS; Bai CH; Su CT; Shen YY; Hsieh JF; Liao AC; Kao CH
    Anticancer Res; 2005; 25(6C):4719-25. PubMed ID: 16334166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
    Cheung TT; Chan SC; Ho CL; Chok KS; Chan AC; Sharr WW; Ng KK; Poon RT; Lo CM; Fan ST
    Liver Transpl; 2011 Oct; 17(10):1218-25. PubMed ID: 21688383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body F-18 FDG PET for hepatocellular carcinoma patients after interventional treatment.
    Cheng MF; Wu YW; Tzen KY; Huang YH; Yen RF
    Neoplasma; 2007; 54(4):342-7. PubMed ID: 17822325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value of 18F-FDG PET/CT in Detecting Adrenal Metastasis in Patients with Hepatocellular Carcinoma.
    Lin Y; Jeng LB; Wang HY; Tsai SC; Lin WY; Kao CH
    Technol Cancer Res Treat; 2015 Oct; 14(5):593-9. PubMed ID: 24945368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of [
    Li S; Peck-Radosavljevic M; Ubl P; Wadsak W; Mitterhauser M; Rainer E; Pinter M; Wang H; Nanoff C; Kaczirek K; Haug A; Hacker M
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1732-1741. PubMed ID: 28555333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solitary splenic metastasis from hepatocellular carcinoma detected on (18)F-FDG PET/CT.
    Kim DH; Jeong SY; Lee SW; Lee J; Ahn BC
    Clin Nucl Med; 2015 Jun; 40(6):e325-7. PubMed ID: 25546205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.